Merck Millipore acquires rights for Biotest microbiology products
Merck Millipore now has exclusive rights to sell Biotest microbiology products in Australia and New Zealand.
In 2011, Merck Millipore acquired German company Biotest, an innovative industrial microbiology company with capabilities in ready-to-use media and hygiene monitoring. Its products are targeted at the pharmaceutical and food and beverage segments.
Biotest’s microbiology products, previously marketed by either of their two trading companies, Heipha and Hycon, are now exclusively available through Merck Millipore. Technical support for the products is also offered.
L'Oréal-UNESCO For Women In Science Fellows announced for ANZ
This year's program honours four women who are reshaping what leadership in research looks...
Peter Beattie appointed Chair of Brandon BioCatalyst
Brandon BioCatalyst has announced new board appointments to continue the scaling of Australian...
Virologist receives GSK Award for AI-based disease detection
Professor Edward Holmes has received the 2025 GSK Award for Research Excellence for his use of...
